34. Neurofibromatosis Clinical trials / Disease details

Clinical trials : 133 / Drugs : 186 - (DrugBank : 67) / Drug target genes : 79 - Drug target pathways : 190

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00727233 (ClinicalTrials.gov)	July 8, 2008	31/7/2008	Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform ...	Phase I Trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, Nexav ...	Neurofibromatosis Type I;Plexiform Neurofibroma	Drug: Nexavar (BAY 43-9006) (Sorafenib);Drug: Toxicity, Pharmacokinetics;Drug: Pharmacodynamics;Drug ...	National Cancer Institute (NCI)	NULL	Completed	3 Years	18 Years	All	9	Phase 1	United States

First Previous1Next Last